Drugs / COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT05381350 Comparator | Jun → Sep 2022 | COVID-19 | Sinovac Research and Development Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | COVID-19 Vaccine (Vero cell), Inactivated (CZ strain) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05381350 ↗ |
| Modality | Vaccine | “COVID-19 Vaccine (Vero cell), Inactivated (CZ strain)” NCT05381350 ↗ |